Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Peng Wang, MD"
3
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT02232243
Completed
Phase 1
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
Peng Wang, MD PhD
ClinicalTrials.gov
NCT02232243
Completed
Phase 1
HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
Peng Wang, MD PhD
NCT03015324
Completed
Phase 1
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Peng Wang, MD PhD
ClinicalTrials.gov
NCT03015324
Completed
Phase 1
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
Peng Wang, MD PhD
NCT03343977
Withdrawn
Phase 1/2
Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Peng Wang, MD PhD
ClinicalTrials.gov
NCT03343977
Withdrawn
Phase 1/2
Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sens...
Peng Wang, MD PhD
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease